Novo Nordisk Shares to Open Lower as Guidance Disappoints -- Market Talk

Dow Jones14:58

0658 GMT - Novo Nordisk shares are set to fall at the European open as investors react to disappointing 2026 guidance, Sydbank senior analyst Soren Lontoft Hansen writes. Shares fell 15% in New York trading Tuesday after the company announced earnings a day earlier than planned. The 2026 forecast is the overriding focus point, and although the market expected a decline in revenue and earnings this year due to headwinds, the forecast is weaker than expected, Hansen says. Novo Nordisk forecasts a drop in adjusted revenue and adjusted earnings of 5% to 13% versus market expectations for drops of 2.1% and 3.6% respectively. "This means that even stronger headwinds are set for 2026 - especially on the price side - than previously expected." A share buyback of up to 15 billion Danish kroner is a positive, he adds. (dominic.chopping@wsj.com)

(END) Dow Jones Newswires

February 04, 2026 01:58 ET (06:58 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2608633044?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 14:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608633044","market":"us","top_or_hot":-1,"title":"Novo Nordisk Shares to Open Lower as Guidance Disappoints -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0658 GMT - <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> shares are set to fall at the European open as investors react to disappointing 2026 guidance, Sydbank senior analyst Soren Lontoft Hansen writes. Shares fell 15% in New York trading Tuesday after the company announced earnings a day earlier than planned. The 2026 forecast is the overriding focus point, and although the market expected a decline in revenue and earnings this year due to headwinds, the forecast is weaker than expected, Hansen says. Novo Nordisk forecasts a drop in adjusted revenue and adjusted earnings of 5% to 13% versus market expectations for drops of 2.1% and 3.6% respectively. \"This means that even stronger headwinds are set for 2026 - especially on the price side - than previously expected.\" A share buyback of up to 15 billion Danish kroner is a positive, he adds. (dominic.chopping@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 04, 2026 01:58 ET (06:58 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novo Nordisk Shares to Open Lower as Guidance Disappoints -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovo Nordisk Shares to Open Lower as Guidance Disappoints -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-04 14:58</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0658 GMT - <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> shares are set to fall at the European open as investors react to disappointing 2026 guidance, Sydbank senior analyst Soren Lontoft Hansen writes. Shares fell 15% in New York trading Tuesday after the company announced earnings a day earlier than planned. The 2026 forecast is the overriding focus point, and although the market expected a decline in revenue and earnings this year due to headwinds, the forecast is weaker than expected, Hansen says. Novo Nordisk forecasts a drop in adjusted revenue and adjusted earnings of 5% to 13% versus market expectations for drops of 2.1% and 3.6% respectively. \"This means that even stronger headwinds are set for 2026 - especially on the price side - than previously expected.\" A share buyback of up to 15 billion Danish kroner is a positive, he adds. (dominic.chopping@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 04, 2026 01:58 ET (06:58 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVOH","symbol_name":"Novo Nordisk A/S B Shares ADRhedged","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2608633044","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2608633044","pubTimestamp":1770188280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0658 GMT - Novo Nordisk shares are set to fall at the European open as investors react to disappointing 2026 guidance, Sydbank senior analyst Soren Lontoft Hansen writes. Shares fell 15% in New York trading Tuesday after the company announced earnings a day earlier than planned. The 2026 forecast is the overriding focus point, and although the market expected a decline in revenue and earnings this year due to headwinds, the forecast is weaker than expected, Hansen says. Novo Nordisk forecasts a drop in adjusted revenue and adjusted earnings of 5% to 13% versus market expectations for drops of 2.1% and 3.6% respectively. \"This means that even stronger headwinds are set for 2026 - especially on the price side - than previously expected.\" A share buyback of up to 15 billion Danish kroner is a positive, he adds. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVOH":"Novo Nordisk A/S B Shares ADRhedged","BK4585":"ETF&股票定投概念","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4532":"文艺复兴科技持仓","BK4599":"减肥药","NVOX":"2倍做多NVO ETF-Defiance","BK4007":"制药","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","NVO":"诺和诺德","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4588":"碎股","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD"},"translate_title":"由于指引令人失望，诺和诺德股价低开——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVOH":0.6,"NVOX":0.6,"NVO":1.95},"content_text":"0658 GMT - Novo Nordisk shares are set to fall at the European open as investors react to disappointing 2026 guidance, Sydbank senior analyst Soren Lontoft Hansen writes. Shares fell 15% in New York trading Tuesday after the company announced earnings a day earlier than planned. The 2026 forecast is the overriding focus point, and although the market expected a decline in revenue and earnings this year due to headwinds, the forecast is weaker than expected, Hansen says. Novo Nordisk forecasts a drop in adjusted revenue and adjusted earnings of 5% to 13% versus market expectations for drops of 2.1% and 3.6% respectively. \"This means that even stronger headwinds are set for 2026 - especially on the price side - than previously expected.\" A share buyback of up to 15 billion Danish kroner is a positive, he adds. (dominic.chopping@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2026 01:58 ET (06:58 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2608633044","isCrawlerRequest":true}